DrugAbuse
Manufacturing · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
517 4th Ave Ste 402, San Diego, Californ...Phone Number
(510) 259-3200Website
www.drugabuse.comRevenue
$10.2 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About DrugAbuse
DrugAbuse Sciences is the first pharmaceutical company dedicated to the development of a range of medicinal products designed to treat states of drugs and alcohol addiction. Doctor Philippe Pouletty, a "serial-entrepreneur", set up DrugAbuse Sciences in 1994, on the strength of his success with his first company, SangStat Medical Corporation, specialising in processes for improving organ grafts. SangStat Medical Corporation is now listed on the NASDAQ in the USA. In the USA and in Europe, there are now over 30 million people in a state of addiction, of which 22 million are alcoholics, 6.3 million cocaine addicts and 2 million heroin addicts. About 7 million of them start a treatment every year, but only 1.8 see it through to the end. This failure rate can be explained by the difficulties of gaining access to treatment, the strict assiduity demanded and the cost. The products of DrugAbuse Sciences provide a solution to overcome these three hurdles and facilitate the physical and psycholRead more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is DrugAbuse your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if DrugAbuse is spiking on competitors!
Product Launch: Get notified when DrugAbuse launches new products
Earning: See what the market has to say on DrugAbuse recently announced quarterly report
Funding: Get notified immidiatlly once DrugAbuse has new funding data
Congratulate Masked Content for being promoted to Masked Content at DrugAbuse
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if DrugAbuse has recently received funding, and reach out quickly before it becomes old news!
DrugAbuse, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if DrugAbuse had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to DrugAbuse
Compare insights from companies similar to DrugAbuse, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
DrugAbuse
$10.2M
51-200
Private
-
1994
N/A
Company Profile Activity
Activity Insights
DrugAbuse is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
DrugAbuse is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about DrugAbuse.
DrugAbuse Tech Stack
A closer look at the technologies used by DrugAbuse
DrugAbuse News & Media
Federal Data Show Sharp Decrease in Teen Drug Use in 2021 - Filter
Among other findings, rates for the three most popular drugs for youth—alcohol, cannabis and vaped nicotine—fell steeply.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding DrugAbuse
Sign Up For FreeTo access detailed company insights
DrugAbuse Sciences is the first pharmaceutical company dedicated to the development of a range of medicinal products designed to treat states of drugs and alcohol addiction. Doctor Philippe Pouletty, a "serial-entrepreneur", set up DrugAbuse Sciences in 1994, on the strength of his success with his first company, SangStat Medical Corporation, speci... Read More
